Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research published in the Journal of the Royal Society of Medicine suggests that empathic, positive messages from doctors may be of small benefit to patients suffering from pain, and improve their satisfaction about the care received.

Image courtesy of Shutterstock

The study, which combined data from 28 clinical trials involving over 6,000 patients, adds weight to the argument that patient outcomes can be improved when doctors enhance how they express empathy and create positive expectations of benefit.

The research team, from Oxford and Southampton universities in the UK, the Netherlands Institute for Health Services Research and Lithuania's Vilnius Gediminas Technical University, analysed a series of randomised clinical trials that looked at the effects of empathy or positive communication in healthcare consultations. These trials included data from consultations on a wide range of clinical conditions including pain, asthma, irritable bowel syndrome, osteoarthritis and recovery after surgery. The researchers also reviewed the effects of positive communication on quality of life and patient satisfaction, based on reports from patients in these trials.

Find out more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.